Home > Publications Database > Oxidative phosphorylation is a key feature of neonatal monocyte immunometabolism promoting myeloid differentiation after birth. > print |
001 | 277424 | ||
005 | 20250406001034.0 | ||
024 | 7 | _ | |a 10.1038/s41467-025-57357-w |2 doi |
024 | 7 | _ | |a pmid:40050264 |2 pmid |
024 | 7 | _ | |a pmc:PMC11885822 |2 pmc |
024 | 7 | _ | |a altmetric:174946600 |2 altmetric |
037 | _ | _ | |a DZNE-2025-00407 |
041 | _ | _ | |a English |
082 | _ | _ | |a 500 |
100 | 1 | _ | |a Ehlers, Greta |b 0 |
245 | _ | _ | |a Oxidative phosphorylation is a key feature of neonatal monocyte immunometabolism promoting myeloid differentiation after birth. |
260 | _ | _ | |a [London] |c 2025 |b Springer Nature |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1743581952_4130 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Neonates primarily rely on innate immune defense, yet their inflammatory responses are usually restricted compared to adults. This is controversially interpreted as a sign of immaturity or essential programming, increasing or decreasing the risk of sepsis, respectively. Here, combined transcriptomic, metabolic, and immunological studies in monocytes of healthy individuals reveal an inverse ontogenetic shift in metabolic pathway activities with increasing age. Neonatal monocytes are characterized by enhanced oxidative phosphorylation supporting ongoing myeloid differentiation. This phenotype is gradually replaced during early childhood by increasing glycolytic activity fueling the inflammatory responsiveness. Microbial stimulation shifts neonatal monocytes to an adult-like metabolism, whereas ketogenic diet in adults mimicking neonatal ketosis cannot revive a neonate-like metabolism. Our findings disclose hallmarks of innate immunometabolism during healthy postnatal immune adaptation and suggest that premature activation of glycolysis in neonates might increase their risk of sepsis by impairing myeloid differentiation and promoting hyperinflammation. |
536 | _ | _ | |a 354 - Disease Prevention and Healthy Aging (POF4-354) |0 G:(DE-HGF)POF4-354 |c POF4-354 |f POF IV |x 0 |
536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 1 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
650 | _ | 2 | |a Oxidative Phosphorylation |2 MeSH |
650 | _ | 2 | |a Humans |2 MeSH |
650 | _ | 2 | |a Monocytes: immunology |2 MeSH |
650 | _ | 2 | |a Monocytes: metabolism |2 MeSH |
650 | _ | 2 | |a Infant, Newborn |2 MeSH |
650 | _ | 2 | |a Cell Differentiation: immunology |2 MeSH |
650 | _ | 2 | |a Glycolysis |2 MeSH |
650 | _ | 2 | |a Myeloid Cells: metabolism |2 MeSH |
650 | _ | 2 | |a Myeloid Cells: immunology |2 MeSH |
650 | _ | 2 | |a Adult |2 MeSH |
650 | _ | 2 | |a Immunity, Innate |2 MeSH |
650 | _ | 2 | |a Female |2 MeSH |
650 | _ | 2 | |a Infant |2 MeSH |
650 | _ | 2 | |a Male |2 MeSH |
650 | _ | 2 | |a Child, Preschool |2 MeSH |
650 | _ | 2 | |a Child |2 MeSH |
650 | _ | 2 | |a Diet, Ketogenic |2 MeSH |
650 | _ | 2 | |a Inflammation: metabolism |2 MeSH |
650 | _ | 2 | |a Inflammation: immunology |2 MeSH |
650 | _ | 2 | |a Sepsis: immunology |2 MeSH |
650 | _ | 2 | |a Sepsis: metabolism |2 MeSH |
650 | _ | 2 | |a Adolescent |2 MeSH |
650 | _ | 2 | |a Transcriptome |2 MeSH |
693 | _ | _ | |0 EXP:(DE-2719)PRECISE-20190321 |5 EXP:(DE-2719)PRECISE-20190321 |e Platform for Single Cell Genomics and Epigenomics at DZNE University of Bonn |x 0 |
700 | 1 | _ | |a Tödtmann, Annika Marie |0 0009-0002-7392-6384 |b 1 |
700 | 1 | _ | |a Holsten, Lisa |0 P:(DE-2719)9001067 |b 2 |e First author |
700 | 1 | _ | |a Willers, Maike |0 0000-0002-8190-273X |b 3 |
700 | 1 | _ | |a Heckmann, Julia |b 4 |
700 | 1 | _ | |a Schöning, Jennifer |b 5 |
700 | 1 | _ | |a Richter, Maximilian |b 6 |
700 | 1 | _ | |a Heinemann, Anna Sophie |b 7 |
700 | 1 | _ | |a Pirr, Sabine |0 0000-0002-3624-6251 |b 8 |
700 | 1 | _ | |a Heinz, Alexander |b 9 |
700 | 1 | _ | |a Dopfer, Christian |b 10 |
700 | 1 | _ | |a Händler, Kristian |0 P:(DE-2719)2812735 |b 11 |
700 | 1 | _ | |a Becker, Matthias |0 P:(DE-2719)2812750 |b 12 |
700 | 1 | _ | |a Büchel, Johanna |b 13 |
700 | 1 | _ | |a Wöckel, Achim |b 14 |
700 | 1 | _ | |a von Kaisenberg, Constantin |0 0000-0001-5554-1937 |b 15 |
700 | 1 | _ | |a Hansen, Gesine |b 16 |
700 | 1 | _ | |a Hiller, Karsten |0 0000-0001-9322-5820 |b 17 |
700 | 1 | _ | |a Schultze, Joachim L |0 P:(DE-2719)2811660 |b 18 |
700 | 1 | _ | |a Härtel, Christoph |b 19 |
700 | 1 | _ | |a Kastenmüller, Wolfgang |0 0000-0002-3835-1485 |b 20 |
700 | 1 | _ | |a Vaeth, Martin |0 0000-0001-8974-7052 |b 21 |
700 | 1 | _ | |a Ulas, Thomas |0 P:(DE-2719)9000845 |b 22 |u dzne |
700 | 1 | _ | |a Viemann, Dorothee |0 0000-0002-9009-3559 |b 23 |
773 | _ | _ | |a 10.1038/s41467-025-57357-w |g Vol. 16, no. 1, p. 2239 |0 PERI:(DE-600)2553671-0 |n 1 |p 2239 |t Nature Communications |v 16 |y 2025 |x 2041-1723 |
856 | 4 | _ | |u https://pub.dzne.de/record/277424/files/DZNE-2025-00407%20SUP%2BSRC.zip |
856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/277424/files/DZNE-2025-00407.pdf |
856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/277424/files/DZNE-2025-00407.pdf?subformat=pdfa |
909 | C | O | |o oai:pub.dzne.de:277424 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)9001067 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 11 |6 P:(DE-2719)2812735 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 12 |6 P:(DE-2719)2812750 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 18 |6 P:(DE-2719)2811660 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 22 |6 P:(DE-2719)9000845 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-354 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Prevention and Healthy Aging |x 0 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 1 |
914 | 1 | _ | |y 2025 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2025-01-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2025-01-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2025-01-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2025-01-02 |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |d 2025-01-02 |
915 | _ | _ | |a IF >= 15 |0 StatID:(DE-HGF)9915 |2 StatID |b NAT COMMUN : 2022 |d 2025-01-02 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NAT COMMUN : 2022 |d 2025-01-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2024-01-30T07:48:07Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2024-01-30T07:48:07Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2025-01-02 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2025-01-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2025-01-02 |
915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2025-01-02 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Peer review |d 2024-01-30T07:48:07Z |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2025-01-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1060 |2 StatID |b Current Contents - Agriculture, Biology and Environmental Sciences |d 2025-01-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2025-01-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1150 |2 StatID |b Current Contents - Physical, Chemical and Earth Sciences |d 2025-01-02 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2025-01-02 |
920 | 1 | _ | |0 I:(DE-2719)1013038 |k AG Schultze |l Clinical Single Cell Omics (CSCO) / Systems Medicine |x 0 |
920 | 1 | _ | |0 I:(DE-2719)5000079 |k AG Becker |l Modular High Performance Computing and Artificial Intelligence |x 1 |
920 | 1 | _ | |0 I:(DE-2719)1013031 |k PRECISE |l Platform for Single Cell Genomics and Epigenomics |x 2 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a I:(DE-2719)1013038 |
980 | _ | _ | |a I:(DE-2719)5000079 |
980 | _ | _ | |a I:(DE-2719)1013031 |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|